Antipsychotic prescribing patterns in the Texas prison system

Journal of the American Academy of Psychiatry and the Law

Volumn 29, Issue 1, 2001, Pages 48-53

  Baillargeon, J ^a   Contreras, S A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; PERPHENAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PRESCRIPTION; PRISONER; SAFETY; SCHIZOPHRENIA; UNITED STATES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DRUG UTILIZATION REVIEW; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PRISONERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TEXAS;

EID: 0035069260     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schizophrenic disorders
2. Criminalizing mental disorder: The comparative arrest rate of the mentally ill
3. The disease profile of Texas prison inmates
4. The mentally ill in prisons: A review
5. Treatment in jails and prisons
6. The prevalence of severe mental disorder among male urban jail detainees: Comparison with the epidemiologic catchment area program
7. Novel antipsychotic agents and their implications for forensic psychiatry
8. Schizophrenia
9. Atypical antipsychotics: Adverse effects, drug interactions, and costs
10. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials
11. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and shcizophreniform disorders: Results of an international collaborative trial
12. Cognitive dysfunction in schizophrenia and its importance to outcome: The place of atypical antipsychotics in treatment
13. The Texas medication algorithm project: Development and implimentation of the schizophrenia algorithm
14. Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics
15. Tardive dyskinesia and ethnicity: Review of the literature
16. Violence and schizophrenia: Clozapine as a specific anti-aggressive agent
17. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital
18. The Texas medication algorithm project (TMAP) schizophrenia algorithm